We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Syncona Limited | LSE:SYNC | London | Ordinary Share | GG00B8P59C08 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.00 | -1.62% | 121.40 | 122.20 | 123.40 | 123.20 | 121.00 | 121.80 | 202,837 | 16:35:29 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Trust,ex Ed,religious,charty | -39.79M | -56.02M | -0.0840 | -14.67 | 821.42M |
From Apr 2019 to Apr 2024
TIDMSYNC
RNS Number : 1926N
Syncona Limited
16 January 2019
16 January 2019
Syncona Limited ("Syncona")
Appointment of Joint Corporate Broker
Syncona is pleased to announce that it has appointed Goldman Sachs International with immediate effect as joint Corporate Broker alongside Numis Securities, who remain joint Corporate Broker.
END
Enquiries:
Investor enquiries Annabel Clay Tel: +44 (0) 20 3981 7940 Goldman Sachs Numis Securities Charlie Lytle Nathan Brown Tom Hartley James Black Lucy Clarke Freddie Barnfield Tel: +44 (0) 207 774 1000 Tel: +44 (0) 207 260 1000
About Syncona
Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
APPCKPDKCBKDCDD
(END) Dow Jones Newswires
January 16, 2019 02:00 ET (07:00 GMT)
1 Year Syncona Chart |
1 Month Syncona Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
